Article
Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
Clinical genetics - 1 Apr 2013
Stuckless S, Green J, Dawson L, Barrett B, Woods M O, Dicks E, Parfrey P S
Abstract excerpt
Lifetime risk of developing endometrial cancer in Lynch syndrome carriers is very high and females are also at an increased risk of developing ovarian cancer. The aim of the study was to determine the impact of gynecological screening in MSH2 mutation carriers. Gynecological cancer incidence and overall survival was compared in female mutation carriers who received gynecological screening (cases) and in matched...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
